1 week ACAD Seeks EU Nod for Rett Syndrome Drug, Outlines 2025 Pipeline Goals Zacks

Acadia files regulatory application for trofinetide to treat Rett syndrome in EU. The company also outlines other pipeline goals for 2025-2026.